COVID-19 and the Professional Athlete
By: Russell S. Gonnering, MD & Attorney Thomas Renz
The vaccines for COVID are a dangerous experiment that may end up causing more damage than they prevent. The vaccines have not had ANY long-term safety studies and there is NO evidence that they are effective against variants. There have been unprecedented numbers of short-term side effects and yet they continue to be pushed by Dr. Fauci and his crew who happen to co-own the intellectual property rights on them.
For professional athletes, these vaccines are a legitimate risk to their careers. There appears to be a substantial risk of immediate adverse reactions, but the long-term risk may be much worse. Ultimately there is nearly ZERO risk of COVID killing a professional athlete and there are numerous safe and effective treatments (as demonstrated by the hundreds of thousands of patients that have been treated with almost no deaths) if an athlete gets sick. Further, the vaccines are not designed to protect against transmission and, when you peel back the statistical games the people selling the vaccine are playing, they only provide a 1% absolute risk reduction.
This leads us to the question, why are professional athletes being used? It seems as though they are being used by the people making money on these vaccines to influence others to get vaccinated. This is sick if it is the case.
If you do not believe us, ask the team or league doctor that is promoting these vaccines what the risk of death from COVID is for people under 40. Then ask them to show you any long-term studies on these vaccines. If you see any, please share them because you will be the first to see them.
The law is not clear on a number of things related to these vaccine experiments but it is clear that you have the right to religious and medical exemptions. The various professional leagues also tend to have strong unions to protect players and coaches. You should ask them about what they are doing to find real information on this and get it to you and if they will stand up for your rights. You should also look at the money spent on advertising with your league and league partners by the pharmaceutical companies. After all this, you should ask yourself, are these people looking out for my safety by pushing this experiment on me or are the looking out for their own pocketbooks.
Below is a short article put together by a highly respected doctor on the medical aspects of this. I hope you take the time to read this and think this through – for your safety and the safety of those you influence.
By Russell S. Gonnering
There is strong evidence to suggest that genetic-based COVID-19 vaccinations will have a significant and direct negative impact on performance for some athletes. These possible negative effects appear to relate, primarily, to the actions these vaccines can have on cardiac health and function.
On July 9, 2021, the European Medicine Agency (EMA) concluded that myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the sac surrounding the heart) was a recognized complication of mRNA COVID-19 vaccines.
 This was issued as a causal relationship and not a random correlation. Such findings have been corroborated in a large study of myocarditis following use of mRNA vaccines in members of the U.S. military.
 Concomitant infection with the Sars-Cov-2 agent was ruled out in these patients. Likewise, a large study recently reported the presence of clinical and subclinical myocarditis in college athletes following Sars-CoV-2 infection
 As infection with Sars-CoV-2 was ruled out in the study of members of the military, this was not a case of concomitant infection. The most likely explanation is a common thread between the two groups, i.e., those who had COVID-19 and those who did not have COVID-19, but underwent vaccination.
Inflammatory myocarditis has a heterogeneous etiology.
 Activated T lymphocytes (specialized white blood cells that play an important role in the immune system) are essential for cardiac damage in virus-induced myocarditis.
 In theory, the mRNA vaccines are produced only in the muscle cells in the arm which took up the initial injection. These muscle cells are induced by the mRNA to produce spike proteins and spike protein fragments that rise to the surface of the cell and stay there.
 They are “anchored”. The immune system recognizes these protruding proteins and produces antibodies as well as activated T lymphocytes, the job of which is to attack infected cells. But what if the cell is not a muscle cell in the arm but a cardiac muscle cell? Presumably that is what happens with myocarditis that occurs as part of a natural infection with the Sars-CoV-2 virus. It appears that the same thing may be happening in the heart muscle cells of individuals that have taken the mRNA vaccine, particularly when one considers that the mRNA vaccines provide the blueprints for the same protein.
The author of this blogreviews several studies concerning this, including biodistribution studies from Pfizer and states:
The great majority of the radioactivity stays in and around the injection site. In the first hours, there’s also some circulating in the plasma. But almost all of that ended up in the liver, and no other tissue was much over 1% of the total.
Could some of the circulating mRNA have been taken up by cardiac muscle? Even if this was “not much over 1% of the total” could this be responsible for the myocarditis and pericarditis seen in predominantly young men following the mRNA injections? Is there some predisposing factor in some people, such as members of the military, that makes this more likely? Could this predisposing factor be more pronounced in professional athletes? It has been postulated that just such a set of predisposing factors do indeed exist for development of myocarditis in athletes following viral infections. Are they also operative for increasing the risk of myocarditis in the professional athlete following mRNA vaccination?
Given this same analysis it seems reasonable to assume that there could be a risk of other, yet unknown impacts on muscle cells throughout the body. At present there are reports of prolonged and possibly permanent weakness after injection as well as neurological issues that could strongly impact coordination.
No long-term studies have been done on these vaccines and so ultimately, we simply do not know all of the potential negative impacts they could have on a professional athlete. The question that we should ask is, with there being a nearly 100% recovery rate from COVID in people under 40, why would a professional athlete risk their career on an experiment?
 https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601, accessed 7/13/2021
 https://jamanetwork.com/journals/jamacardiology/fullarticle/2780548, accessed 7/13/2021
 https://www.nature.com/articles/s41569-020-00435-x, accessed 7/13/2021
 Liu, P. et al. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6, 429–434 (2000).
 https://www.nytimes.com/interactive/2020/health/moderna-covid-19-vaccine.html, accessed 7/13/2021
 https://blogs.sciencemag.org/pipeline/archives/2021/05/04/spike-protein-behavior, accessed 7/13/2021